Companion Diagnostics Market Research Report: Market size, Industry outlook, Market Forecast, Demand Analysis,Market Share, Market Report 2018-2023
  • 1-614-588-8538 (Ext: 101)
  • US Toll Free

Companion diagnostics market
Companion Diagnostics Market: By Technology (PCR, Polymerase Chain Reaction (PCR), ISH, IHC, Others) Applications (Breast Cancer, Lung Cancer, Gastric Cancer, Others) End Users (Pharmaceuticals, Laboratries, Research Institutes, Others) & Geography - Forecast(2018 - 2023)
Report Code : HCR 0055
Updated Date: 31 May, 2018  
4

Copies sold

    Client Rating

  • Report Description
  • Table of Contents
  • Tables And Figures
  • Customization Options
1. Companion Diagnostics Market Overview
2. Executive Summary
3. Companion Diagnostics - Market Landscape
   3.1. Market Share Analysis
   3.2. Comparative Analysis
      3.2.1. Product Benchmarking
      3.2.2. End user profiling
      3.2.3. Patent Analysis
      3.2.4. Top 5 Financials Analysis
4. Companion Diagnostics - Market Forces
   4.1. Market Drivers
   4.2. Market Constraints
   4.3. Market Challenges
   4.4. Attractiveness of the Industry
      4.4.1. Power of Suppliers
      4.4.2. Power of Customers
      4.4.3. Threat of New entrants
      4.4.4. Threat of Substitution
      4.4.5. Degree of Competition
5. Companion Diagnostics Market – Government Regulations
6. Companion Diagnostics Market – Strategic Analysis
   6.1. Value Chain Analysis
   6.2. Pricing Analysis
   6.3. Opportunities Analysis
   6.4. Product/Market Life Cycle Analysis
7. Companion Diagnostics Market – By Technology
   7.1. Polymerase Chain Reaction (PCR)
   7.2. Sequencing-based
   7.3. In Situ Hybridization (ISH)
   7.4. Immunohistochemistry (IHC)
   7.5. Others
8. Companion Diagnostics Market – By Applications
   8.1. Breast Cancer
   8.2. Lung Cancer
   8.3. Colorectal Cancer
   8.4. Melanoma
   8.5. Gastric Cancer
   8.6. Others
9. Companion Diagnostics Market – By End Users
   9.1. Pharmaceutical Companies
   9.2. Reference Laboratries
   9.3. CRO
   9.4. Hospitals
   9.5. Research Institutes
10. Companion Diagnostics - Market Geographic Analysis
   10.1. Americas
   10.2. Europe
   10.3. APAC
   10.4. ROW
11. Market Entropy
   11.1. New Product Launches
   11.2. M&As, Collaborations, JVs and Partnerships
12. Company Profiles (Overview, Financials, SWOT Analysis – Top 5 Companies, Developments, Product Portfolio)
   12.1. Abbott Laboratories 
   12.2. Advanced Cell Diagnostics Inc. 
   12.3. Agilent Technologies, Inc.
   12.4. Biomérieux
   12.5. Biogenex Laboratories
   12.6. Danaher Corporation
   12.7. GE Healthcare
   12.8. Myriad Genetics, Inc.
   12.9. Qiagen N.V.
   12.10. Roche Diagnostics
   12.11. Thermo Fisher Scientific, Inc.
   12.12. R-Biopharm AG
   12.13. Cypher Genomics
   12.14. Flagship Biosciences
   12.15. Applied Proteomics
   12.16. Ignyta, Inc.
   12.17. Madison Vaccines, Inc.
   12.18. Ventana Medical Systems, Inc.
*More than 30 Companies are profiled in this Research Report, Complete List available on Request*
"*Financials would be provided on a best efforts basis for private companies"
13. Appendix
   13.1. Abbreviations
   13.2. Sources
   13.3. Research Methodology
   13.4. Bibliography
   13.5. Compilation of Expert Insights
   13.6. Disclaimer
Companion diagnostics is an in-vitro diagnostic tool that assists physicians in optimizing treatment decisions for their patients. The companion diagnostic is crucial for the safe and effective use of the drug and have been widely developed for myriad of cancer and other therapies. Each companion diagnostic test is specifically designed to be paired with a specific drug. Such tests can also save significant healthcare costs by targeting the patients with most effective therapy.

In this report different market aspects are explored with particular focus on key market drivers, challenges, constraints and market landscape. The Global market has been thoroughly analyzed and carefully segmented by geographic locations based on major economic and topographical regions.

The market for Companion diagnostics is classified into several categories based on technology, applications and end users.

Polymerase Chain Reaction (PCR) is the biggest revenue generating segment by type of technology used.

Major market players are profiled along with company overview, financial status, business strategies, product portfolio, recent trends and developments.

Sample Companies Profiled in this Report are:
  • Abbott Laboratories
  • Advanced Cell Diagnostics Inc.
  • Agilent Technologies, Inc.
  • Biomérieux
  • Biogenex Laboratories.
  • 30+.

The report details current market potential and future market growth in this industry. Overall the report contains the most detailed and in depth segmentation and analysis of the Global Companion diagnostics Market during the forecast period 2015-2020.
List of Tables:

Table 1: Companion Diagnostics Market Overview 2017-2023
Table 2: Companion Diagnostics Market Leader Analysis 2017-2018 (US$)
Table 3: Companion Diagnostics Market Product Analysis 2017-2018 (US$)
Table 4: Companion Diagnostics Market End User Analysis 2017-2018 (US$)
Table 5: Companion Diagnostics Market Patent Analysis 2013-2018* (US$)
Table 6: Companion Diagnostics Market Financial Analysis 2017-2018 (US$)
Table 7: Companion Diagnostics Market Driver Analysis 2017-2018 (US$)
Table 8: Companion Diagnostics Market Challenges Analysis 2017-2018 (US$)
Table 9: Companion Diagnostics Market Constraint Analysis 2017-2018 (US$)
Table 10: Companion Diagnostics Market Supplier Bargaining Power Analysis 2017-2018 (US$)
Table 11: Companion Diagnostics Market Buyer Bargaining Power Analysis 2017-2018 (US$)
Table 12: Companion Diagnostics Market Threat of Substitutes Analysis 2017-2018 (US$)
Table 13: Companion Diagnostics Market Threat of New Entrants Analysis 2017-2018 (US$)
Table 14: Companion Diagnostics Market Degree of Competition Analysis 2017-2018 (US$)
Table 15: Companion Diagnostics Market Value Chain Analysis 2017-2018 (US$)
Table 16: Companion Diagnostics Market Pricing Analysis 2018-2023 (US$)
Table 17: Companion Diagnostics Market Opportunities Analysis 2018-2023 (US$)
Table 18: Companion Diagnostics Market Product Life Cycle Analysis 2018-2023 (US$)
Table 19: Companion Diagnostics Market Supplier Analysis 2017-2018 (US$)
Table 20: Companion Diagnostics Market Distributor Analysis 2017-2018 (US$)
Table 21: Companion Diagnostics Market Trend Analysis 2017-2018 (US$)
Table 22: Companion Diagnostics Market Size 2017 (US$)
Table 23: Companion Diagnostics Market Forecast Analysis 2018-2023 (US$)
Table 24: Companion Diagnostics Market Sales Forecast Analysis 2018-2023 (Units)
Table 25: Companion Diagnostics Market, Revenue & Volume, By Technology, 2018-2023 ($)
Table 26: Companion Diagnostics Market By Technology, Revenue & Volume, By Polymerase Chain Reaction (PCR), 2018-2023 ($)
Table 27: Companion Diagnostics Market By Technology, Revenue & Volume, By Sequencing-based, 2018-2023 ($)
Table 28: Companion Diagnostics Market By Technology, Revenue & Volume, By In Situ Hybridization (ISH), 2018-2023 ($)
Table 29: Companion Diagnostics Market By Technology, Revenue & Volume, By Immunohistochemistry (IHC), 2018-2023 ($)
Table 30: Companion Diagnostics Market By Technology, Revenue & Volume, By Technology 5, 2018-2023 ($)
Table 31: Companion Diagnostics Market, Revenue & Volume, By Application, 2018-2023 ($)
Table 32: Companion Diagnostics Market By Application, Revenue & Volume, By Breast Cancer, 2018-2023 ($)
Table 33: Companion Diagnostics Market By Application, Revenue & Volume, By Lung Cancer, 2018-2023 ($)
Table 34: Companion Diagnostics Market By Application, Revenue & Volume, By Colorectal Cancer, 2018-2023 ($)
Table 35: Companion Diagnostics Market By Application, Revenue & Volume, By Melanoma, 2018-2023 ($)
Table 36: Companion Diagnostics Market By Application, Revenue & Volume, By Gastric Cancer, 2018-2023 ($)
Table 37: Companion Diagnostics Market, Revenue & Volume, By End Use, 2018-2023 ($)
Table 38: Companion Diagnostics Market By End Use, Revenue & Volume, By Pharmaceutical Companies, 2018-2023 ($)
Table 39: Companion Diagnostics Market By End Use, Revenue & Volume, By Reference Laboratries, 2018-2023 ($)
Table 40: Companion Diagnostics Market By End Use, Revenue & Volume, By CRO, 2018-2023 ($)
Table 41: Companion Diagnostics Market By End Use, Revenue & Volume, By Hospitals, 2018-2023 ($)
Table 42: Companion Diagnostics Market By End Use, Revenue & Volume, By Research Institutes, 2018-2023 ($)
Table 43: North America Companion Diagnostics Market, Revenue & Volume, By Technology, 2018-2023 ($)
Table 44: North America Companion Diagnostics Market, Revenue & Volume, By Application, 2018-2023 ($)
Table 45: North America Companion Diagnostics Market, Revenue & Volume, By End Use, 2018-2023 ($)
Table 46: South america Companion Diagnostics Market, Revenue & Volume, By Technology, 2018-2023 ($)
Table 47: South america Companion Diagnostics Market, Revenue & Volume, By Application, 2018-2023 ($)
Table 48: South america Companion Diagnostics Market, Revenue & Volume, By End Use, 2018-2023 ($)
Table 49: Europe Companion Diagnostics Market, Revenue & Volume, By Technology, 2018-2023 ($)
Table 50: Europe Companion Diagnostics Market, Revenue & Volume, By Application, 2018-2023 ($)
Table 51: Europe Companion Diagnostics Market, Revenue & Volume, By End Use, 2018-2023 ($)
Table 52: APAC Companion Diagnostics Market, Revenue & Volume, By Technology, 2018-2023 ($)
Table 53: APAC Companion Diagnostics Market, Revenue & Volume, By Application, 2018-2023 ($)
Table 54: APAC Companion Diagnostics Market, Revenue & Volume, By End Use, 2018-2023 ($)
Table 55: Middle East & Africa Companion Diagnostics Market, Revenue & Volume, By Technology, 2018-2023 ($)
Table 56: Middle East & Africa Companion Diagnostics Market, Revenue & Volume, By Application, 2018-2023 ($)
Table 57: Middle East & Africa Companion Diagnostics Market, Revenue & Volume, By End Use, 2018-2023 ($)
Table 58: Russia Companion Diagnostics Market, Revenue & Volume, By Technology, 2018-2023 ($)
Table 59: Russia Companion Diagnostics Market, Revenue & Volume, By Application, 2018-2023 ($)
Table 60: Russia Companion Diagnostics Market, Revenue & Volume, By End Use, 2018-2023 ($)
Table 61: Israel Companion Diagnostics Market, Revenue & Volume, By Technology, 2018-2023 ($)
Table 62: Israel Companion Diagnostics Market, Revenue & Volume, By Application, 2018-2023 ($)
Table 63: Israel Companion Diagnostics Market, Revenue & Volume, By End Use, 2018-2023 ($)
Table 64: Top Companies 2017 (US$)Companion Diagnostics Market, Revenue & Volume
Table 65: Product Launch 2017-2018Companion Diagnostics Market, Revenue & Volume
Table 66: Mergers & Acquistions 2017-2018Companion Diagnostics Market, Revenue & Volume


List of Figures:

Figure 1: Overview of Companion Diagnostics Market 2017-2023
Figure 2: Market Share Analysis for Companion Diagnostics Market 2017 (US$)
Figure 3: Product Comparison in Companion Diagnostics Market 2017-2018 (US$)
Figure 4: End User Profile for Companion Diagnostics Market 2017-2018 (US$)
Figure 5: Patent Application and Grant in Companion Diagnostics Market 2013-2018* (US$)
Figure 6: Top 5 Companies Financial Analysis in Companion Diagnostics Market 2017-2018 (US$)
Figure 7: Market Entry Strategy in Companion Diagnostics Market 2017-2018
Figure 8: Ecosystem Analysis in Companion Diagnostics Market 2017
Figure 9: Average Selling Price in Companion Diagnostics Market 2017-2023
Figure 10: Top Opportunites in Companion Diagnostics Market 2017-2018
Figure 11: Market Life Cycle Analysis in Companion Diagnostics Market Market Life Cycle Analysis in 3D Printing
Figure 12: GlobalBy TechnologyCompanion Diagnostics Market Revenue, 2018-2023 ($)
Figure 13: GlobalBy ApplicationCompanion Diagnostics Market Revenue, 2018-2023 ($)
Figure 14: GlobalBy End UseCompanion Diagnostics Market Revenue, 2018-2023 ($)
Figure 15: Global Companion Diagnostics Market - By Geography
Figure 16: Global Companion Diagnostics Market Value & Volume, By Geography, 2018-2023 ($) 
Figure 17: Global Companion Diagnostics Market CAGR, By Geography, 2018-2023 (%)
Figure 18: North America Companion Diagnostics Market Value & Volume, 2018-2023 ($)
Figure 19: US Companion Diagnostics Market Value & Volume, 2018-2023 ($)
Figure 20: US GDP and Population, 2017-2018 ($)
Figure 21: US GDP – Composition of 2017, By Sector of Origin
Figure 22: US Export and Import Value & Volume, 2017-2018 ($)
Figure 23: Canada Companion Diagnostics Market Value & Volume, 2018-2023 ($)
Figure 24: Canada GDP and Population, 2017-2018 ($)
Figure 25: Canada GDP – Composition of 2017, By Sector of Origin
Figure 26: Canada Export and Import Value & Volume, 2017-2018 ($)
Figure 27: Mexico Companion Diagnostics Market Value & Volume, 2018-2023 ($)
Figure 28: Mexico GDP and Population, 2017-2018 ($)
Figure 29: Mexico GDP – Composition of 2017, By Sector of Origin
Figure 30: Mexico Export and Import Value & Volume, 2017-2018 ($)
Figure 31: South America Companion Diagnostics Market South America 3D Printing Market Value & Volume, 2018-2023 ($)
Figure 32: Brazil Companion Diagnostics Market Value & Volume, 2018-2023 ($)
Figure 33: Brazil GDP and Population, 2017-2018 ($)
Figure 34: Brazil GDP – Composition of 2017, By Sector of Origin
Figure 35: Brazil Export and Import Value & Volume, 2017-2018 ($)
Figure 36: Venezuela Companion Diagnostics Market Value & Volume, 2018-2023 ($)
Figure 37: Venezuela GDP and Population, 2017-2018 ($)
Figure 38: Venezuela GDP – Composition of 2017, By Sector of Origin
Figure 39: Venezuela Export and Import Value & Volume, 2017-2018 ($)
Figure 40: Argentina Companion Diagnostics Market Value & Volume, 2018-2023 ($)
Figure 41: Argentina GDP and Population, 2017-2018 ($)
Figure 42: Argentina GDP – Composition of 2017, By Sector of Origin
Figure 43: Argentina Export and Import Value & Volume, 2017-2018 ($)
Figure 44: Ecuador Companion Diagnostics Market Value & Volume, 2018-2023 ($)
Figure 45: Ecuador GDP and Population, 2017-2018 ($)
Figure 46: Ecuador GDP – Composition of 2017, By Sector of Origin
Figure 47: Ecuador Export and Import Value & Volume, 2017-2018 ($)
Figure 48: Peru Companion Diagnostics Market Value & Volume, 2018-2023 ($)
Figure 49: Peru GDP and Population, 2017-2018 ($)
Figure 50: Peru GDP – Composition of 2017, By Sector of Origin
Figure 51: Peru Export and Import Value & Volume, 2017-2018 ($)
Figure 52: Colombia Companion Diagnostics Market Value & Volume, 2018-2023 ($)
Figure 53: Colombia GDP and Population, 2017-2018 ($)
Figure 54: Colombia GDP – Composition of 2017, By Sector of Origin
Figure 55: Colombia Export and Import Value & Volume, 2017-2018 ($)
Figure 56: Costa Rica Companion Diagnostics Market Costa Rica 3D Printing Market Value & Volume, 2018-2023 ($)
Figure 57: Costa Rica GDP and Population, 2017-2018 ($)
Figure 58: Costa Rica GDP – Composition of 2017, By Sector of Origin
Figure 59: Costa Rica Export and Import Value & Volume, 2017-2018 ($)
Figure 60: Europe Companion Diagnostics Market Value & Volume, 2018-2023 ($)
Figure 61: U.K Companion Diagnostics Market Value & Volume, 2018-2023 ($)
Figure 62: U.K GDP and Population, 2017-2018 ($)
Figure 63: U.K GDP – Composition of 2017, By Sector of Origin
Figure 64: U.K Export and Import Value & Volume, 2017-2018 ($)
Figure 65: Germany Companion Diagnostics Market Value & Volume, 2018-2023 ($)
Figure 66: Germany GDP and Population, 2017-2018 ($)
Figure 67: Germany GDP – Composition of 2017, By Sector of Origin
Figure 68: Germany Export and Import Value & Volume, 2017-2018 ($)
Figure 69: Italy Companion Diagnostics Market Value & Volume, 2018-2023 ($)
Figure 70: Italy GDP and Population, 2017-2018 ($)
Figure 71: Italy GDP – Composition of 2017, By Sector of Origin
Figure 72: Italy Export and Import Value & Volume, 2017-2018 ($)
Figure 73: France Companion Diagnostics Market Value & Volume, 2018-2023 ($)
Figure 74: France GDP and Population, 2017-2018 ($)
Figure 75: France GDP – Composition of 2017, By Sector of Origin
Figure 76: France Export and Import Value & Volume, 2017-2018 ($)
Figure 77: Netherlands Companion Diagnostics Market Value & Volume, 2018-2023 ($)
Figure 78: Netherlands GDP and Population, 2017-2018 ($)
Figure 79: Netherlands GDP – Composition of 2017, By Sector of Origin
Figure 80: Netherlands Export and Import Value & Volume, 2017-2018 ($)
Figure 81: Belgium Companion Diagnostics Market Value & Volume, 2018-2023 ($)
Figure 82: Belgium GDP and Population, 2017-2018 ($)
Figure 83: Belgium GDP – Composition of 2017, By Sector of Origin
Figure 84: Belgium Export and Import Value & Volume, 2017-2018 ($)
Figure 85: Spain Companion Diagnostics Market Value & Volume, 2018-2023 ($)
Figure 86: Spain GDP and Population, 2017-2018 ($)
Figure 87: Spain GDP – Composition of 2017, By Sector of Origin
Figure 88: Spain Export and Import Value & Volume, 2017-2018 ($)
Figure 89: Denmark Companion Diagnostics Market Value & Volume, 2018-2023 ($)
Figure 90: Denmark GDP and Population, 2017-2018 ($)
Figure 91: Denmark GDP – Composition of 2017, By Sector of Origin
Figure 92: Denmark Export and Import Value & Volume, 2017-2018 ($)
Figure 93: APAC Companion Diagnostics Market Value & Volume, 2018-2023 ($)
Figure 94: China Companion Diagnostics Market Value & Volume, 2018-2023
Figure 95: China GDP and Population, 2017-2018 ($)
Figure 96: China GDP – Composition of 2017, By Sector of Origin
Figure 97: China Export and Import Value & Volume, 2017-2018 ($)Companion Diagnostics Market China Export and Import Value & Volume, 2017-2018 ($)
Figure 98: Australia Companion Diagnostics Market Value & Volume, 2018-2023 ($)
Figure 99: Australia GDP and Population, 2017-2018 ($)
Figure 100: Australia GDP – Composition of 2017, By Sector of Origin
Figure 101: Australia Export and Import Value & Volume, 2017-2018 ($)
Figure 102: South Korea Companion Diagnostics Market Value & Volume, 2018-2023 ($)
Figure 103: South Korea GDP and Population, 2017-2018 ($)
Figure 104: South Korea GDP – Composition of 2017, By Sector of Origin
Figure 105: South Korea Export and Import Value & Volume, 2017-2018 ($)
Figure 106: India Companion Diagnostics Market Value & Volume, 2018-2023 ($)
Figure 107: India GDP and Population, 2017-2018 ($)
Figure 108: India GDP – Composition of 2017, By Sector of Origin
Figure 109: India Export and Import Value & Volume, 2017-2018 ($)
Figure 110: Taiwan Companion Diagnostics Market Taiwan 3D Printing Market Value & Volume, 2018-2023 ($)
Figure 111: Taiwan GDP and Population, 2017-2018 ($)
Figure 112: Taiwan GDP – Composition of 2017, By Sector of Origin
Figure 113: Taiwan Export and Import Value & Volume, 2017-2018 ($)
Figure 114: Malaysia Companion Diagnostics Market Malaysia 3D Printing Market Value & Volume, 2018-2023 ($)
Figure 115: Malaysia GDP and Population, 2017-2018 ($)
Figure 116: Malaysia GDP – Composition of 2017, By Sector of Origin
Figure 117: Malaysia Export and Import Value & Volume, 2017-2018 ($)
Figure 118: Hong Kong Companion Diagnostics Market Hong Kong 3D Printing Market Value & Volume, 2018-2023 ($)
Figure 119: Hong Kong GDP and Population, 2017-2018 ($)
Figure 120: Hong Kong GDP – Composition of 2017, By Sector of Origin
Figure 121: Hong Kong Export and Import Value & Volume, 2017-2018 ($)
Figure 122: Middle East & Africa Companion Diagnostics Market Middle East & Africa 3D Printing Market Value & Volume, 2018-2023 ($)
Figure 123: Russia Companion Diagnostics Market Russia 3D Printing Market Value & Volume, 2018-2023 ($)
Figure 124: Russia GDP and Population, 2017-2018 ($)
Figure 125: Russia GDP – Composition of 2017, By Sector of Origin
Figure 126: Russia Export and Import Value & Volume, 2017-2018 ($)
Figure 127: Israel Companion Diagnostics Market Value & Volume, 2018-2023 ($)
Figure 128: Israel GDP and Population, 2017-2018 ($)
Figure 129: Israel GDP – Composition of 2017, By Sector of Origin
Figure 130: Israel Export and Import Value & Volume, 2017-2018 ($)
Figure 131: Entropy Share, By Strategies, 2017-2018* (%)Companion Diagnostics Market
Figure 132: Developments, 2017-2018*Companion Diagnostics Market
Figure 133: Company 1 Companion Diagnostics Market Net Revenue, By Years, 2017-2018* ($)
Figure 134: Company 1 Companion Diagnostics Market Net Revenue Share, By Business segments, 2017 (%)
Figure 135: Company 1 Companion Diagnostics Market Net Sales Share, By Geography, 2017 (%)
Figure 136: Company 2 Companion Diagnostics Market Net Revenue, By Years, 2017-2018* ($)
Figure 137: Company 2 Companion Diagnostics Market Net Revenue Share, By Business segments, 2017 (%)
Figure 138: Company 2 Companion Diagnostics Market Net Sales Share, By Geography, 2017 (%)
Figure 139: Company 3 Companion Diagnostics Market Net Revenue, By Years, 2017-2018* ($)
Figure 140: Company 3 Companion Diagnostics Market Net Revenue Share, By Business segments, 2017 (%)
Figure 141: Company 3 Companion Diagnostics Market Net Sales Share, By Geography, 2017 (%)
Figure 142: Company 4 Companion Diagnostics Market Net Revenue, By Years, 2017-2018* ($)
Figure 143: Company 4 Companion Diagnostics Market Net Revenue Share, By Business segments, 2017 (%)
Figure 144: Company 4 Companion Diagnostics Market Net Sales Share, By Geography, 2017 (%)
Figure 145: Company 5 Companion Diagnostics Market Net Revenue, By Years, 2017-2018* ($)
Figure 146: Company 5 Companion Diagnostics Market Net Revenue Share, By Business segments, 2017 (%)
Figure 147: Company 5 Companion Diagnostics Market Net Sales Share, By Geography, 2017 (%)
Figure 148: Company 6 Companion Diagnostics Market Net Revenue, By Years, 2017-2018* ($)
Figure 149: Company 6 Companion Diagnostics Market Net Revenue Share, By Business segments, 2017 (%)
Figure 150: Company 6 Companion Diagnostics Market Net Sales Share, By Geography, 2017 (%)
Figure 151: Company 7 Companion Diagnostics Market Net Revenue, By Years, 2017-2018* ($)
Figure 152: Company 7 Companion Diagnostics Market Net Revenue Share, By Business segments, 2017 (%)
Figure 153: Company 7 Companion Diagnostics Market Net Sales Share, By Geography, 2017 (%)
Figure 154: Company 8 Companion Diagnostics Market Net Revenue, By Years, 2017-2018* ($)
Figure 155: Company 8 Companion Diagnostics Market Net Revenue Share, By Business segments, 2017 (%)
Figure 156: Company 8 Companion Diagnostics Market Net Sales Share, By Geography, 2017 (%)
Figure 157: Company 9 Companion Diagnostics Market Net Revenue, By Years, 2017-2018* ($)
Figure 158: Company 9 Companion Diagnostics Market Net Revenue Share, By Business segments, 2017 (%)
Figure 159: Company 9 Companion Diagnostics Market Net Sales Share, By Geography, 2017 (%)
Figure 160: Company 10 Companion Diagnostics Market Net Revenue, By Years, 2017-2018* ($)
Figure 161: Company 10 Companion Diagnostics Market Net Revenue Share, By Business segments, 2017 (%)
Figure 162: Company 10 Companion Diagnostics Market Net Sales Share, By Geography, 2017 (%)
Figure 163: Company 11 Companion Diagnostics Market Net Revenue, By Years, 2017-2018* ($)
Figure 164: Company 11 Companion Diagnostics Market Net Revenue Share, By Business segments, 2017 (%)
Figure 165: Company 11 Companion Diagnostics Market Net Sales Share, By Geography, 2017 (%)
Figure 166: Company 12 Companion Diagnostics Market Net Revenue, By Years, 2017-2018* ($)
Figure 167: Company 12 Companion Diagnostics Market Net Revenue Share, By Business segments, 2017 (%)
Figure 168: Company 12 Companion Diagnostics Market Net Sales Share, By Geography, 2017 (%)
Figure 169: Company 13 Companion Diagnostics Market Net Revenue, By Years, 2017-2018* ($)
Figure 170: Company 13 Companion Diagnostics Market Net Revenue Share, By Business segments, 2017 (%)
Figure 171: Company 13 Companion Diagnostics Market Net Sales Share, By Geography, 2017 (%)
Figure 172: Company 14 Companion Diagnostics Market Net Revenue, By Years, 2017-2018* ($)
Figure 173: Company 14 Companion Diagnostics Market Net Revenue Share, By Business segments, 2017 (%)
Figure 174: Company 14 Companion Diagnostics Market Net Sales Share, By Geography, 2017 (%)
Figure 175: Company 15 Companion Diagnostics Market Net Revenue, By Years, 2017-2018* ($)
Figure 176: Company 15 Companion Diagnostics Market Net Revenue Share, By Business segments, 2017 (%)
Figure 177: Company 15 Companion Diagnostics Market Net Sales Share, By Geography, 2017 (%)
Please select Licence
Single User Licence:
US $4250
Corporate User Licence:
US $6250
Related Reports
0px;">Scroll